ESKETAMINE HYDROCHLORIDE NASAL SPRAY (Spravato®)

Clinical Indication

In combination with a SSRI or SNRI for adults with treatment-resistant Major Depressive Disorder

Comments

Administration in specialist clinic only

Date of classification

June 2020

Review date

August 2021

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).